Hepatocyte Growth Factor Exerts Its Anti-Inflammatory Action by Disrupting Nuclear Factor-κB Signaling
- 1 July 2008
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 173 (1) , 30-41
- https://doi.org/10.2353/ajpath.2008.070583
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Mechanisms of Disease: regulation of RANTES (CCL5) in renal diseaseNature Clinical Practice Nephrology, 2007
- Tubular Epithelial Cell Dedifferentiation Is Driven by the Helix-Loop-Helix Transcriptional Inhibitor Id1Journal of the American Society of Nephrology, 2007
- Downregulation of SnoN Expression in Obstructive Nephropathy Is Mediated by an Enhanced Ubiquitin-Dependent DegradationJournal of the American Society of Nephrology, 2006
- Activation of PI3K–Akt–GSK3β pathway mediates hepatocyte growth factor inhibition of RANTES expression in renal tubular epithelial cellsBiochemical and Biophysical Research Communications, 2005
- A Novel Mechanism by which Hepatocyte Growth Factor Blocks Tubular Epithelial to Mesenchymal TransitionJournal of the American Society of Nephrology, 2005
- Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of actionAmerican Journal of Physiology-Renal Physiology, 2004
- Chemokines and chemokine receptors are involved in the resolution or progression of renal diseaseKidney International, 2003
- Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathyKidney International, 2002
- Transcription factor-κB (NF-κB) and renal diseaseKidney International, 2001
- Inhibition of nuclear factor-κB activation reduces cortical tubulointerstitial injury in proteinuric ratsKidney International, 1999